Summary
Methylphenidate (MP) binds to the cocaine binding site on the dopamine transporter and inhibits reuptake of dopamine, but does not appear to have the same abuse potential as cocaine. This study, part of a comprehensive effort to identify a drug treatment for cocaine abuse, investigates the effect of choice of calculation technique and of solvent model on the conformational potential energy surface (PES) of MP and a rigid methylphenidate (RMP) analogue which exhibits the same dopamine transporter binding affinity as MP. Conformational analysis was carried out by the AM1 and AM1/SM5.4 semiempirical molecular orbital methods, a molecular mechanics method (Tripos force field with the dielectric set equal to that of vacuum or water) and the HF/6-31G* molecular orbital method in vacuum phase. Although all three methods differ somewhat in the local details of the PES, the general trends are the same for neutral and protonated MP. In vacuum phase, protonation has a distinctive effect in decreasing the regions of space available to the local conformational minima. Solvent has little effect on the PES of the neutral molecule and tends to stabilize the protonated species. The random search (RS) conformational analysis technique using the Tripos force field was found to be capable of locating the minima found by the molecular orbital methods using systematic grid search. This suggests that the RS/Tripos force field/vacuum phase protocol is a reasonable choice for locating the local minima of MP. However, the Tripos force field gave significantly larger phenyl ring rotational barriers than the molecular orbital methods for MP and RMP. For both the neutral and protonated cases, all three methods found the phenyl ring rotational barriers for the RMP conformers/invertamers (denoted as cte, tte, and cta) to be: cte, tte> MP > cta. Solvation has negligible effect on the phenyl ring rotational barrier of RMP. The B3LYP/6-31G* density functional method was used to calculate the phenyl ring rotational barrier for neutral MP and gave results very similar to those of the HF/6-31G* method.
Similar content being viewed by others
Abbreviations
- AM1:
-
Austin Model
- SM5.4:
-
Solvent Model, parameterization 5.4
- MP:
-
methylphenidate
- RMP:
-
rigid methylphenidate
- nMP:
-
neutral methylphenidate
- pMP:
-
protonated methylphenidate
- nRMP:
-
neutral rigid methylphenidate
- pRMP:
-
protonated rigid methylphenidate
- QSAR:
-
quantitative structure-activity relationships
- RMSD :
-
root mean square deviation
- RS:
-
random search
- SAR:
-
struc-ture-activity relationships
- CoMFA:
-
Comparative Molecular Field Analysis
- DAT:
-
dopamine transporter
- PES:
-
potential energy surface
- HF/6-31G*:
-
Hartree-Fock 6-31G* basis set. For the RMP notations: cte (ring cistrans stereochemistry, phenyl group equatorial), tte (ring trans, trans stereochemistry, phenyl group equatorial), and cta (ring cis, trans stereochemistry, phenyl group axial).
References
M.J. Kuhar M.C. Ritz J.W. Boja (1991) TINS, 14 299
Chen, N.H. and Reith, M.E.A., In Reith, M.E.A. (Ed.), Contemporary Neuroscience: Neurotransmitter Transporters: Structure, Function, and Regulation, Humana Press, Totowa, NJ, 1997, pp. 53–109.
S. Singh (2000) Chem. Rev., 100 925
F.I. Carroll (2003) J. Med. Chem., 46 1775
T. Prisinzano K.C. Rice M.H. Baumann R.B. Rothman (2004) Curr. Med. Chem.–Central Nervous System Agents, 4 47
R.D. Cramer D.E. Patterson J.D. Bunce (1988) J.Am. Chem. Soc., 110 5959
F.I. Carroll Y. Gao M.A. Rahman P. Abrams K. Parham A.H. Lewin J.W. Boja M.J. Kuhar (1991) J. Med. Chem., 34 2719
M. Froimowitz (1993) J. Comput. Chem., 14 934
F.I. Carroll S.W. Mascarella M.A. Kuzemko Y. Gao P. Abraham A.H. Lewin J.W. Boja M.J. Kuhar (1994) J. Med. Chem., 37 2865
B. Yang J. Wright M.E. Eldefrawi S. Pou A.D. MacKerell SuffixJr. (1994) J. Am. Chem. Soc., 116 8722
S.F. Lieske B. Yang M.E. Eldefrawi A.D. MacKerell SuffixJr. J. Wright (1998) J. Med. Chem., 41 864
N. Zhu A. Harrison M.L. Trudell C.L. Klein-Stevens (1999) Struct. Chem., 10 91
I.C. Muszynski L. Scapozza K.-A. Kovar G. Folkers (1999) Quant. Struct.-Act. Relat., 18 342
B.T. Hoffman T. Kopajtic J.L. Katz A.H. Newman (2000) J. Med. Chem., 43 4151
H.M.L. Davies V. Gilliatt L.A. Kuhn E. Saikali P. Ren P.S. Hammond G.J. Sexton S.R. Childers (2001) J. Med. Chem., 44 1509
C.G. Zhan F. Zheng D.W. Landry (2003) J. Am. Chem. Soc., 125 2462
S. Paula M.R. Tabet S.M. Keenan W.J. Welsh J. Ball (2003) J. Mol. Biol., 325 515
S. Paula M.R. Tabet C.D. Farr A.D. Norman J. Ball (2004) J. Med. Chem., 47 133
S.S. Kulkarni P. Grundt T. Kopajtic J.L. Katz A.H. Newman (2004) J. Med. Chem., 47 3388
H. Yuan A.P. Kozikowski P.A. Petukhov (2004) J. Med. Chem., 47 6137
A.H. Newman S. Izenwasser M.J. Robarge R.H. Kline (1999) J. Med. Chem., 42 3502
M.J. Robarge G.E. Agoston S. Izenwasser T. Kopajtic C. George J.L. Katz A.H. Newman (2000) J. Med. Chem., 43 1085
M. Froimowitz K.-M. Wu J. Rodrigo C. George (2000) J. Comput.-Aided Mol. Des., 14 135
M. Froimowitz C. George (1998) J. Chem. Inf. Comp. Sci., 38 506
S.S. Kulkarni A.H. Newman W.J. Houlihan (2002) J. Med. Chem., 45 4119
P. Benedetti R. Mannhold G. Cruciani M. Pastor (2002) J. Med. Chem., 45 1577
S. Wang S. Sakamuri I.J. Enyedy A.P. Kozikowski W.A. Zaman K.M. Johnson (2001) Bioorg. Med. Chem. Lett., 9 1753
K.S. Patrick R.W. Caldwell R.M. Ferris G.R. Breese (1987) J. Pharm. Expt. Ther., 241 152
N.D. Volkow Y.-S. Ding J.S. Fowler G.-J. Wang J. Logan S.J. Gatley S. Dewey C. Ashby J. Liebermann R. Hitzemann A.P. Wolf (1995) Arch. Gen. Psych., 52 456
Y.-S. Ding J.S. Fowler N.D. Volkow J. Logan S.J. Gatley Y. Sugano (1995) J. Nucl. Med., 36 2298
S.J. Gatley Y.-S. Ding N.D. Volkow R. Chen Y. Sugano J.S. Fowler (1995) Eur. J. Pharmacol., 281 141
N.D. Volkow Y.-S. Ding J.S. Fowler G.-J. Wang J. Logan S.J. Gatley D.J. Schlyer N. Pappas (1995) J. Nucl. Med., 36 2162
D.L. Thai M.T. Sapko C.T. Reiter D.E. Bierer J.M. Perel (1998) J. Med. Chem., 41 591
N.D. Volkow G.-J. Wang J.S. Fowler S.J. Gatley J. Logan Y.-S. Ding S.L. Dewey R. Hitzemann A.N. Gifford N.R. Pappas (1999) J. Pharm. Expt. Ther., 288 14
N.D. Volkow J.S. Fowler S.J. Gatley S.L. Dewey G.J. Wang J. Logan Y.S. Ding D. Franceschi A. Gifford A. Morgan N. Pappas P. King (1999) Synapse, 31 59
Volkow, N.D., Wang, G.-J., Fowler, J.S., Fischman, M., Foltin, R., Abumrad, N.N., Gatley, S.J., Logan, E., Wong, C., Gifford, A., Ding, Y.-S., Hitzemann, R. and Pappas, N., Life Sci., 65 (1999) PL7.
N.D. Volkow J.S. Fowler G.-J. Wang Y.-S. Ding S.J. Gatley (2002) Eur. Neuropsychopharmacol., 12 557
N.D. Volkow G.-J. Wang J.S. Fowler J. Logan D. Franceschi L. Maynard Y.-S. Ding S.J. Gatley A. Gifford W. Zhu J.M. Swanson (2002) Synapse, 43 181
P. Seeman B.K. Madras (2002) Behavioral Brain Res., 130 79
J.M. Swanson N.D. Volkow (2003) Neurosci. Biobehavioral Rev., 27 615
B.E. Leonard D. McCartan J. White D.J. King (2004) Human Psychopharmacol., 19 151
M.M. Schweri P. Skolnick M.F. Rafferty K.C. Rice A.J. Janowsky S.M. Paul (1985) J. Neurochem., 45 1062
M.M. Schweri (1990) Neuropharmacology, 29 901
M.M. Schweri (1994) Synapse, 16 188
H.M. Deutsch Q. Shi E. Gruszecka-Kowalik M. Schweri (1996) J. Med. Chem., 39 1201
M. Froimowitz H.M. Deutsch Q. Shi K.-M. Wu R. Glaser I. Adin C. George M.M. Schweri (1997) Bioorg. Med. Chem. Lett., 7 1213
R. Glaser I. Adin D. Shiftan Q. Shi H.M. Deutsch G. George K.-M. Wu M. Froimowitz (1998) J. Org. Chem., 63 1785
H.M. Deutsch (1998) Med. Chem. Res., 8 91
M. Froimowitz K.-M. Wu C. George D. VanDerveer Q. Shi. H.M. Deutsch (1998) Struct. Chem., 4 295
H.M. Deutsch T. Dunn X. Ye M.M. Schweri (1999) Synth. Med. Chem. Res., 9 213
H.K. Wayment H. Deutsch M.M. Schweri J.O. Schenk (1999) J. Neurochem., 72 1266
H.M. Deutsch X. Ye Q. Shi Z. Liu M.M. Schweri (2001) Eur. J. Med. Chem., 36 303
M.M. Schweri H.M. Deutsch A.T. Massey S.G. Holtzman (2002) J. Pharm. Expt. Ther., 301 527
Deutsch, H.M., Kim, D.I., Holtzman, S.G., Schweri, M.M. and Spealman, R.D., The Synthesis and Evaluation of New Methylphenidates: Restricted Rotation Analogs, Preliminary results presented at the College on the Problems of Drug Dependence, 64th Annual Meeting, June 9--13, Quebec City, Canada, 2002.
P.C. Meltzer P. Wang P. Blundell B.K. Madras (2003) J. Med. Chem., 46 1538
H.M.L. Davies D.W. Hopper T. Hansen Q. Liu S.R. Childers (2004) Bioorg. Med. Chem., 14 1799
M. Froimowitz K.S. Patrick V. Cody (1995) Pharm. Res., 12 1430
M.C. Nicklaus S. Wang J. Driscoll G.W.A. Milne (1995) Bioorg. Med. Chem., 3 411
M. Vieth J.D. Hirst I. Brooks C.L. (1998) J. Comput.-Aided Mol. Des., 12 563
J. Boström P.-O. Norrby T. Liljefors (1998) J. Comput.-Aided Mol. Des., 12 383
A.K. Debnath (1999) J. Med. Chem., 42 249
E. Perola P.S. Charifson (2004) J. Med. Chem., 47 2499
Kim, K.H., Greco, G. and Novellino, E., In Kubinyi, H., Folkers, G. and Martin, Y.C. (Eds.), 3D QSAR in Drug Design: Recent Advances, Kluwer Academic, Dordrecht, 1998, pp. 257–315.
F. Guarnieri H. Weinstein (1996) J. Am. Chem. Soc., 118 5580
Hopfinger, A.J. and Tokarski, J.S., In Charifson, P.S. (Ed.), Practical Application of Computer-Aided Drug Design, Marcel Dekker, New York, 1997, pp. 105–164.
J. Barnett-Norris F. Guarnieri D.P. Hurst P.H. Reggio (1998) J. Med. Chem., 41 4861
J. Barnett-Norris D.P. Hurst D.L. Lynch F. Guarnieri A. Makriyannis P.H. Reggio (2002) J. Med. Chem., 45 3649
P.A. Greenidge S.A.M. Merette R. Beck G. Dodson C.A. Goodwin M.F. Scully J. Spencer J. Weiser J.J. Deadman (2003) J. Med. Chem., 46 1293
D. Bernard A. Coop A.D. MacKerell SuffixJr. (2003) J. Am. Chem. Soc., 125 3101
M. Clark R.D. Cramer N. Opdenbosch ParticleVan (1989) J. Comput. Chem., 10 982
M.J.S. Dewar Y. Yate-Ching (1990) Inorg. Chem., 29 3881
M.J.S. Dewar E.G. Zoebisch (1988) J. Mol. Struct. (Theochem), 49 1
M.J.S. Dewar E.G. Zoebisch E.E. Healy J.J.P. Stewart (1985) J. Am. Chem. Soc., 107 3902
C.C. Chambers G.D. Hawkins C.J. Cramer D.G. Truhlar (1996) J. Phys. Chem., 100 16385
W.J. Hehre R. Ditchfield J.A. Pople (1972) J. Chem. Phys., 56 2257
J.L. Berfield L.C. Wang M.E.A. Reith (1999) J. Biol. Chem., 274 4876
C. Xu M.E.A. Reith (1996) J. Pharm. Expt. Ther., 278 1340
P.J. Stephens F.J. Devlin C.F. Chabalowski M.J. Frisch (1994) J. Phys. Chem., 98 11623
M. Saunders (1987) J. Am. Chem. Soc., 109 3150
Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewski, V.G., Montgomery, Jr., J.A., Stratmann, R.E., Burant, J.C., Dapprich, S., Millam, J.M., Daniels, A.D., Kudin, K.N., Strain, M.C., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R.., Menucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G.A., Ayala, P.Y., Cui, Q., Morokuma, K., Rega, N., Salvador, P., Dannenberg, J.J., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Cioslowski, J., Ortiz, J.V., Baboul, A.G., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Gomperts, R., Martin, R.L., Fox, D.J., Keith, T.A., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Challacombe, M., Gill, P.M.W., Johnson, B.G., Chen, W., Wong, M.W., Andres, J.L., Gonzalez, C., Head-Gordon, M., Replogle, E.S. and Pople, J.A., Gaussian 98, Revision A.11.3, Gaussian 98, Revision A.11.3, Gaussian Inc., Wallingford, CT (2002).
M. Cossi V.,R. Barone C.J. Tomasi (1996) Chem. Phys. Lett., 255 327
M.T. Cances V. Mennucci J. Tomasi (1997) J. Chem. Phys., 107 3032
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gilbert, K.M., Skawinski, W.J., Misra, M. et al. Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods. J Comput Aided Mol Des 18, 719–738 (2004). https://doi.org/10.1007/s10822-004-7610-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-004-7610-1